Abbott Valuation Multiples

Abbott Overview

About Abbott

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Founded

1900

HQ

Employees

115.0K

Website

abbott.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $46B

EBITDA: $12B

EV

$172B

Valuation Multiples

Multiples.vc

Start free trial

Abbott Financials

Abbott reported last 12-month revenue of $46B and EBITDA of $12B.

In the same LTM period, Abbott generated $26B in gross profit, $12B in EBITDA, and $9B in net income.

Abbott P&L

In the most recent fiscal year, Abbott reported revenue of $44B and EBITDA of $12B.

Abbott expects next 12-month revenue of XXX and NTM EBITDA of XXX

Abbott Stock Performance

Abbott has current market cap of $167B, and enterprise value of $172B.

Abbott's stock price is $96.00.

Abbott Valuation Multiples

Abbott trades at 3.7x EV/Revenue multiple, and 14.1x EV/EBITDA.

Abbott Financial Valuation Multiples

As of April 21, 2026, Abbott has market cap of $167B and EV of $172B.

Equity research analysts estimate Abbott's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Abbott has a P/E ratio of 18.1x.

Abbott Margins & Growth Rates

Abbott's revenue in the last 12 month grew by 12%.

Abbott's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Abbott's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Abbott's rule of X is 60% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Abbott Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Abbott M&A Activity

Abbott acquired XXX companies to date.

Last acquisition by Abbott was on XXXXXXXX, XXXXX. Abbott acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Abbott Investment Activity

Abbott invested in XXX companies to date.

Abbott made its latest investment on XXXXXXXX, XXXXX. Abbott invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).